Omniscope

At Omniscope, we read your immune system in high definition: one cell at a time. We are building the world’s largest immune databank. Our vision? Healthcare for everyone, everywhere. 🚀 Thanks for the feature, Google Cloud! 🔗 Learn more about Omniscope technology: https://www.omniscope.ai/ #GoogleCloudSummit #ScienceIsWeAll Google, Vijay Vaswani

'There just aren't enough female founders building tech businesses to invest in' Much like Hephzi's post below, Ive been told this a number of times and well, I call Bull$hit! In fact I co-hosted with Nichola Bates 4 lunches for almost 100 Female Founders in tech across Europe this Summer! Yes, there are still far more men building tech than women, and yes you may have to do a bit more work to find them, but they exist. Here are a few more to add to Hephzi's list of 6: Lynnette Ang - Co-founder & CGO of Omniscope Dr. Sioned Fôn Jones Co-founder of BoobyBiome Denise Johansson & Monika Liikamaa Co-founders of Enfuce Afarin Kheirati Co-founder of Roadern Cassie Yusofi & Magdalena Okrzeja Co-founders of Aimars Svenja Tegtmeier & Marita Sanchez de la Cerda co-founders of SAIZ I encourage everyone, if you know a female founder who is building tech, please re-share this post and tag her/them. Let's highlight as many as we can! 💪 #WomenBuildingTech 👉 PASS IT ON!

How will we make the world a better place? By building it together. At Omniscope our co-founder and CGO Lynnette Ang has been tireless in ensuring diversity in our cohorts and data: to ensure women and men from all parts of the world are represented and not left behind. For investors, funding female founders is your opportunity to build a better world- and there are many incredible female founders as Jennifer Hoffman correctly points out. Let us lift each other up- we have far more in common than what divides us. The future of our species is in our hands.

We are presenting our poster today at #SITC 2024! Come by poster 215 to explore how AI tools and multimodality are shaping the future of immune monitoring. 📃 https://lnkd.in/dEuk5jKC 🤝 https://lnkd.in/dxKeXwas #ScienceIsWeAll #NoTCellLeftBehind Holger Heyn

Excited to present at #SITC 2024! 💬 Discover how AI tools and multimodality are shaping the future of immune monitoring at Omniscope Poster #215. 🤝 Let’s connect for a meeting: https://lnkd.in/d62a77R7 #ScienceIsWeAll Society for Immunotherapy of Cancer (SITC)

Leverage Omniscope’s AI-enabled immune-profiling technology to identify key immune correlates and optimize vaccine efficacy and duration. 📝 Learn more in our new Application Note, now available: https://lnkd.in/d-iMC3Xb #ScienceIsWeAll #NoTCellLeftBehind #WVCEU

💬 Omniscope leverages AI and immune profiling to ensure vaccines are effective and long-lasting. Learn more at our #WVCEU presentation today! 🏛️ Don’t forget to stop by booth 115 for daily demos of Omniscope’s Immune Portal. #ScienceIsWeAll #NoTCellLeftBehind Holger Heyn

💬 Join us on October 29th for our presentation by Dr. Holger Heyn and Dr. Christian Brander. 🏛️ Don’t forget to stop by Booth 115 for daily demos of Omniscope’s Immune Portal and discover how AI-powered immune profiling can boost vaccine development! Book a time to meet: https://lnkd.in/dJw2dgPC #ScienceIsWeAll #WVCEU

Omniscope technology can precisely distinguish and cluster T cell signals from different COVID vaccines, revealing shared sequences across manufacturers. This can help compare vaccines and improve their development. As part of the BAXERNA 2.0 consortium, Omniscope will evaluate different mRNA vaccine candidates and their effects on the immune system to help prioritize the best option for development. More info: https://lnkd.in/d_cQG34j Meet with us at #WVCEU: https://lnkd.in/d58Jpzgg #ScienceIsWeAll

#WVCEU incoming! 💬 Join us for our presentation by Dr. Holger Heyn and Dr. Christian Brander on October 29th, 15:40 at theatre 6. 🏛️ Visit our booth to learn how Omniscope technologies accelerate vaccine development by characterizing immune response. Schedule a time to meet us: https://lnkd.in/eEmx5f_W #ScienceIsWeAll